Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) FCF Margin (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 2 years of FCF Margin data on record, last reported at 906.42% in Q3 2025.

  • For Q3 2025, FCF Margin changed N/A year-over-year to 906.42%; the TTM value through Sep 2025 reached 1667.01%, changed N/A, while the annual FY2021 figure was 8319.25%, N/A changed from the prior year.
  • FCF Margin reached 906.42% in Q3 2025 per COEP's latest filing, up from 1194.3% in the prior quarter.
  • Across five years, FCF Margin topped out at 25.03% in Q4 2021 and bottomed at 3763.35% in Q1 2025.